Ligand Pharmaceuticals Inc
NASDAQ:LGND

Watchlist Manager
Ligand Pharmaceuticals Inc Logo
Ligand Pharmaceuticals Inc
NASDAQ:LGND
Watchlist
Price: 115.45 USD -5.43% Market Closed
Market Cap: 2.1B USD
Have any thoughts about
Ligand Pharmaceuticals Inc?
Write Note

Ligand Pharmaceuticals Inc
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Ligand Pharmaceuticals Inc
Depreciation & Amortization Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
Ligand Pharmaceuticals Inc
NASDAQ:LGND
Depreciation & Amortization
$35.8m
CAGR 3-Years
-6%
CAGR 5-Years
15%
CAGR 10-Years
29%
Abbvie Inc
NYSE:ABBV
Depreciation & Amortization
$8.4B
CAGR 3-Years
-1%
CAGR 5-Years
34%
CAGR 10-Years
27%
Gilead Sciences Inc
NASDAQ:GILD
Depreciation & Amortization
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Depreciation & Amortization
$5.6B
CAGR 3-Years
18%
CAGR 5-Years
23%
CAGR 10-Years
11%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Depreciation & Amortization
$208.6m
CAGR 3-Years
20%
CAGR 5-Years
16%
CAGR 10-Years
12%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Depreciation & Amortization
$469.5m
CAGR 3-Years
20%
CAGR 5-Years
19%
CAGR 10-Years
25%

See Also

What is Ligand Pharmaceuticals Inc's Depreciation & Amortization?
Depreciation & Amortization
35.8m USD

Based on the financial report for Jun 30, 2024, Ligand Pharmaceuticals Inc's Depreciation & Amortization amounts to 35.8m USD.

What is Ligand Pharmaceuticals Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
29%

Over the last year, the Depreciation & Amortization growth was -18%. The average annual Depreciation & Amortization growth rates for Ligand Pharmaceuticals Inc have been -6% over the past three years , 15% over the past five years , and 29% over the past ten years .

Back to Top